ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EVOK Evoke Pharma Inc

0.45
-0.001 (-0.22%)
After Hours
Last Updated: 06:06:47
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Evoke Pharma Inc EVOK NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.001 -0.22% 0.45 06:06:47
Open Price Low Price High Price Close Price Previous Close
0.464 0.4351 0.47 0.465 0.451
more quote information »

Recent News

Date Time Source Heading
17/5/202406:02GLOBEEvoke Pharma to Present Additional GIMOTI Healthcare..
15/5/202406:58EDGAR2Form ARS/A - Annual Report to Security Holders: [Amend]
15/5/202406:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202406:15GLOBEEvoke Pharma Reports First Quarter 2024 Financial Results
15/5/202406:15EDGAR2Form 8-K - Current report
15/5/202406:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
15/5/202406:00EDGAR2Form 8-K - Current report
17/4/202422:30GLOBEEvoke Pharma to Host Virtual Key Opinion Leader (KOL)..
22/3/202407:15GLOBEEvoke Pharma Announces Senior Leadership Transition with..
15/3/202407:05GLOBEEvoke Pharma Reports Fourth Quarter and Full Year 2023..
08/3/202408:10GLOBEEvoke Pharma to Report Fourth Quarter and Full Year 2023..
24/2/202408:15EDGAR2Form 8-K - Current report
21/2/202408:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/2/202401:00EDGAR2Form 8-K - Current report
14/2/202423:30GLOBEEvoke Pharma Announces Closing of $7.5 Million Public..
10/2/202409:15EDGAR2Form 8-K - Current report
10/2/202409:14EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
09/2/202423:30GLOBEEvoke Pharma Announces Pricing of Underwritten Public..
08/2/202422:50EDGAR2Form S-1/A - General form for registration of securities..
11/1/202413:38EDGAR2Form S-1/A - General form for registration of securities..
05/1/202408:30EDGAR2Form S-1/A - General form for registration of securities..
20/12/202300:30EDGAR2Form S-1/A - General form for registration of securities..
16/12/202308:30EDGAR2Form S-1/A - General form for registration of securities..
30/11/202301:00EDGAR2Form 8-K - Current report
28/11/202308:30EDGAR2Form 8-K - Current report
28/11/202300:30GLOBEEvoke Pharma Announces FDA Orange Book Listing of New GIMOTI..
23/11/202308:15EDGAR2Form 8-K - Current report
15/11/202300:30GLOBEUnited States Patent and Trademark Office (USPTO) Grants..
10/11/202308:30EDGAR2Form S-1 - General form for registration of securities under..
10/11/202301:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202301:00EDGAR2Form 8-K - Current report
10/11/202300:30GLOBEEvoke Pharma Reports Third Quarter 2023 Financial Results
01/11/202323:30EDGAR2Form 8-K - Current report
31/10/202323:30GLOBEEvoke Pharma & EVERSANA Unveil Cost Savings Real-World Data..
18/10/202323:30GLOBEEvoke Pharma’s Abstract Entitled “Superiority of Nasal Spray..
13/10/202307:30EDGAR2Form 8-K - Current report
14/9/202322:30GLOBEEvoke Pharma Receives Notice of Allowance from USPTO for..
11/8/202323:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/8/202323:03EDGAR2Form 8-K - Current report
10/8/202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:30GLOBEEvoke Pharma Reports Second Quarter 2023 Financial Results
07/8/202322:30GLOBEEvoke Pharma and EVERSANA Announce Abstract Acceptance at..
25/7/202322:30GLOBEEvoke Pharma and EVERSANA Announce Abstract Selection for..
21/7/202323:00EDGAR2Form 8-K - Current report
14/6/202322:30GLOBEEvoke Pharma to Host First Key Opinion Leader Webinar on..